Prof Tsochatzis is a Prof of hepatology and honorary consultant at the University College London Institute for Liver and Digestive Health in the Royal Free Hospital and head of the Centre for Metabolic Liver Diseases.

He leads the specialist multidisciplinary service in non-alcoholic fatty liver disease and has an active research programme. His clinical interests include non-invasive fibrosis assessment, cirrhosis and portal hypertension and metabolic liver disease including wilson’s disease and iron disorders.

Prof Tsochatzis finished his specialty training and PhD in Hippokration General Hospital in Greece, before moving to the Royal Free Hospital for his post-doc research. He has been a consultant hepatologist and a clinical academic since 2014. Since 2019, he has been a member of the scientific committee and governing board of the European Association for the Study of the Liver.

He sits on national and international clinical guideline committees, serves as specialist advisor to the National Institute for Health and Care Excellence, and is actively involved in undergraduate and postgraduate education.




• Tsochatzis E, Crossan C, Longworth L, Gurusamy K, Rodriguez-Peralvarez M, Mantzoukis K, O’Brien J, Thalassinos E, Papastergiou V, Noel-Storr A, Davidson B, Burroughs AK «Cost-effectiveness of non-invasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C», Hepatology 2014; In Press
• Tsochatzis E, Bruno S, Isgro G, Hall A, Theocharidou E, Manousou P, Dhillon AP, Burroughs AK, Luong TV «Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis», J Hepatol 2014;60: 948-54
• Tsochatzis EA, Bosch J, Burroughs AK «Liver cirrhosis», The Lancet, 2014;383: 1749-61
• Tsochatzis E, Bosch J, Burroughs AK «Future treatments of liver cirrhosis», Expert reviews in Gastroenterology and Hepatology 2014; 8:571-81
• Papastergiou V, Tsochatzis E, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O’Beirne J, Patch D, Thorburn D, Burroughs AK «Nine scoring models for short term mortality in alcoholic hepatitis: a cross validation in a biopsy proven cohort», Alimentary Pharmacology and Therapeutics 2014; 39:721-32
• Rodriguez-Peralvarez M, Tsochatzis E, Naveas MC, Pieri G, Garcia-Caparros C, O’Beirne J, Poyato-Gonzales A, Ferrin-Sanchez G, Montero-Alvarez JL, Patch D, Thorburn D, Briceno J, De la Mata M, AK Burroughs «Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma», Journal of Hepatology 2013; 59:1193-9
• Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, Germani G, Davies N, Yu D, Luong TV, Dhillon AP, Thorburn D, Patch D, O’Beirne J, Meyer T, Burroughs AK «Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma», Liver International 2013; 33:944-9
• Papastergiou V, Burroughs AK, Tsochatzis EA «Prognosis and treatment of patients with acute alcoholic hepatitis», Expert reviews in Gastroenterology and Hepatology 2014; 8:471-86
• Manousou P, Cholongitas E, Samonakis D, Tsochatzis E, Corbani A, Dhillon AP, Davidson J, Rodríguez-Perálvarez M, Patch D, O’Beirne J, Thorburn D, Luong T, Rolles K, Davidson B, McCormick PA, Hayes P, Burroughs AK. «Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes» Gut. 2014; 63: 1005-13
• Papastergiou V, Tsochatzis E, Rodriguez-Peralvarez M, Thalassinos E, Pieri, G, Manousou P, Germani G, Rigamonti C, Arvaniti V, Karatapanis S, Burroughs AK «Biochemical criteria at one year are not robust indicators of response to ursodeoxycholic acid in primary biliary cirrhosis: results from a 29-year cohort study», Alimentary, Pharmacology & Therapeutics 2013; 38:1354-64

Prof Tsochatzis's research interests include fatty liver disease, cirrhosis and complications, and non-invasive fibrosis assessment.